These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18688858)

  • 1. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer.
    Cheng WL; Wang CS; Huang YH; Liang Y; Lin PY; Hsueh C; Wu YC; Chen WJ; Yu CJ; Lin SR; Lin KH
    Int J Cancer; 2008 Oct; 123(8):1787-96. PubMed ID: 18688858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
    Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
    Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
    Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
    Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLPI promotes the gastric cancer growth and metastasis by regulating the expression of P53, Bcl-2 and Caspase-8.
    Du XY; Liu X; Wang ZJ; Wang YY
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1495-1501. PubMed ID: 28429358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases.
    Wex T; Treiber G; Venerito M; Leodolter A; Peitz U; Kuester D; Hritz I; Krueger S; Roessner A; Malfertheiner P
    Biol Chem; 2006 Jul; 387(7):893-901. PubMed ID: 16913839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
    Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
    Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
    Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
    Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylori-related gastroduodenal diseases.
    Wex T; Sokic-Milutinovic A; Todorovic V; Bjelovic M; Milosavljevic T; Pesko P; Malfertheiner P
    Dig Dis; 2004; 22(4):390-5. PubMed ID: 15812165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa.
    Wex T; Mönkemüller K; Kuester D; Weise S; Kropf S; Fry LC; Stahr A; Völkel S; Roessner A; Malfertheiner P
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):150-8. PubMed ID: 19212204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer].
    Guo L; Guo XB; Jiang JL; Zhang JN; Ji J; Liu BY; Zhu ZG; Yu YY
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):436-41. PubMed ID: 21055170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lymphangiogenic factor SOX 18: a key indicator to stage gastric tumor progression.
    Eom BW; Jo MJ; Kook MC; Ryu KW; Choi IJ; Nam BH; Kim YW; Lee JH
    Int J Cancer; 2012 Jul; 131(1):41-8. PubMed ID: 21796627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of early growth response-1 in human gastric cancer and its relationship with tumor cell behaviors and prognosis.
    Myung E; Park YL; Kim N; Chung CY; Park HB; Park HC; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
    Pathol Res Pract; 2013 Nov; 209(11):692-9. PubMed ID: 24011795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.
    Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D
    World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells.
    Zuo J; Zhang C; Ren C; Pang D; Li Y; Xie X; Tang Z; Jiang X
    Clin Transl Oncol; 2015 Apr; 17(4):314-21. PubMed ID: 25319722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of secretory leucocyte protease inhibitor in colon carcinoma].
    Guo J; Li G; Zhuang J; Ji C; Liu F; Tao G; Dong H
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):898-901. PubMed ID: 23803207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.